Determinants of Myelosuppression in the Treatment of Non-small Cell Lung Cancer with Cisplatin-containing Chemotherapy

• MATSUI Kaoru

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• MASUDA Noriyuki

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• UCHIDA Yasuo

  Scientific Affairs Department, Pharmaceuticals Group. Nippon Kayaku Co., Ltd.,

• FUKUOKA Masahiro

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• NEGORO Shunichi

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• YANA Takashi

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• KUSUNOKI Yoko

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• KUDOH Shinzoh

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• KAWASE Ichiro

  2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital

• KAWAHARA Masaaki

  Department of Internal Medicine, National Kinki Central Hospital

• OGAWARA Mitsumasa

  Department of Internal Medicine, National Kinki Central Hospital

• KODAMA Nagahisa

  Department of Internal Medicine, National Kinki Central Hospital

• KUBOTA Kaoru

  Department of Internal Medicine, National Kinki Central Hospital

• FURUSE Kiyoyuki

  Department of Internal Medicine, National Kinki Central Hospital

Journal

• Japanese journal of cancer research : gann

  Japanese journal of cancer research : gann 87 (7), 781-786, 1996-07-31

Keywords

• Cisplatin-based chemotherapy
• Non-small cell lung cancer
• Bone marrow suppression
• Elderly patient
• Recursive partitioning and amalgamation

Details

• CRID: 1570854174679592320
• NII Article ID: 10008074652
• NII Book ID: AA00690844
• ISSN: 09105050
• Web Site: https://search.jamas.or.jp/link/ui/1996247033
• Text Lang: en
• Data Source:
  • CiNii Articles